Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes

BJU International

Volumn 87, Issue 4, 2001, Pages 402-407

  Cartledge, J J ^a   Eardley, I ^a   Morrison, J F B ^b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Advanced glycation end products (AGEs); Aminoguanidine; Diabetes mellitus; Erectile dysfunction

Indexed keywords

ACETYLCHOLINE; ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; CONTROLLED STUDY; CORPUS CAVERNOSUM; DIABETES MELLITUS; DIET; ERECTILE DYSFUNCTION; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE RELAXATION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES; IMPOTENCE; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH; NITRIC OXIDE; PENILE DISEASES; RATS; RATS, WISTAR;

EID: 0035075785     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2001.00067.x     Document Type: Article

References (25)

1. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications
2. Pathogenic effects of advanced glycosylation: Biochemical, biologic, and clinical implications for diabetes and aging
3. Glycated hemoglobin: Methodologies and clinical applications
4. A circulating marker of advanced glycation
5. Endothelial and neuronal derived nitric oxide-mediated relaxation of corpus cavernosal smooth muscle in a new rat in vitro model of erectile function
6. Impairment of corpus cavernosal smooth muscle relaxation by glycosylated human haemoglobin
7. Physiology of erection
8. Impairment of endothelium-dependent relaxation by increasing percentages of glycosylated human hemoglobin
9. Nitric oxide-mediated corpus cavernosal smooth muscle relaxation is impaired in ageing and diabetes
10. Effect of chronic experimental diabetes on vascular smooth muscle function in rabbit carotid artery
11. Oxygen tree radicals abolish endothelium-dependent relaxation in diabetic rat aorta
12. Contraction and relaxation of aortas from diabetic rats: Effects of chronic anti-oxidant and aminoguanidine treatments
13. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking
14. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept
15. Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats
16. Aminoguanidine: A drug proposed for the prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro
17. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation
18. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes
19. Role of oxidative stress in development of complications in diabetes
20. The effect of superoxide dismutase on nitric oxide-mediated and electrical field stimulated diabetic rabbit cavernosal smooth muscle relaxation
21. 2 in human umbilical vein endothelial cells cultured in high glucose medium
22. Functional and structural abnormalities in the nerves of Type 1 diabetic baboons: Aminoguanidine treatment does not improve nerve function
23. The effects of diabetes on nitric oxidemediated responses in rat corpus cavernosum
24. Lipids and the endothelium
25. Atherogenic lipids and endothelial dysfunction: Mechanisms in the genesis of ischemic syndromes